ADA example [Bioanalytics]

posted by mittyri – Russia, 2019-03-18 22:20 (562 d 11:10 ago) – Posting: # 20047
Views: 2,930

Hi Helmut,

Thank you so much for the detailed answer!

» » Even in analytical methodology (say QC samples): isn't possible to handle that values (as they are) for example for the mean evaluation for some level of QC sample?

» Not sure what you mean here.

Sorry for incomplete/incorrect question.
Say ADA, getting cut-off point (IV B FDA)
What would be a best tactics for cut-off point selection?
Say the data of healthy volunteers is {100, BLOQ, BLOQ}


Edit: Guidance linked. [Helmut]

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
21,091 posts in 4,398 threads, 1,469 registered users;
online 18 (2 registered, 16 guests [including 6 identified bots]).
Forum time: Thursday 10:31 CEST (Europe/Vienna)

In these days, a man who says a thing cannot be done
is quite apt to be interrupted by some idiot doing it.    Elbert Green Hubbard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5